RxDoctor Payments Data

Evan Nelson, MD

Family Medicine · Roswell, NMNPI 1053375212

Payments from drug & device makers

$656in general payments, 2019–2025

Across 34 payments — averaging $19.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$120
  • Harmony Biosciences LLC$104
  • Teva Pharmaceuticals USA, Inc.$104
  • Axsome Therapeutics, Inc.$80
  • Lundbeck LLC$57
  • Neurocrine Biosciences, Inc.$57
  • plus $134 from 5 others

What the payments were for

  • Food & beverage$656100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$656 in reported general payments places this provider in the 75th percentile of 717 family medicine providers in New Mexico.

See all family medicine providers in New Mexico

Medicare billing

Part B allowed, 2024
$33,502
Medicare patients
71
Services billed
290

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate32$119,501
Combivent RespimatIpratropium/Albuterol Sulfate49$23,249
OzempicSemaglutide19$17,929
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl52$14,028
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine133$3,733
Quetiapine Fumarate80$2,373
Duloxetine Hcl60$2,223
Paliperidone ErPaliperidone22$2,050
Alprazolam299$2,029
Dexlansoprazole DrDexlansoprazole12$1,774
Fluoxetine Hcl72$1,645
Gabapentin115$1,494
Mirtazapine72$1,490
Memantine Hcl ErMemantine Hcl15$1,407
Varenicline Tartrate11$1,396

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$16$119,50132 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 717 family medicine providers in New Mexico.

Other family medicine in Roswell

See the full list for New Mexico

Where these figures come from

Is this you, or does something look wrong? →